TWD 15.4
(-2.6%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 51.01 Million TWD | -31.63% |
2022 | 74.61 Million TWD | 25.78% |
2021 | 59.32 Million TWD | -14.41% |
2020 | 69.31 Million TWD | -6.01% |
2019 | 73.75 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 12.26 Million TWD | 9.75% |
2024 Q2 | 12.26 Million TWD | 0.0% |
2023 Q3 | 11.17 Million TWD | -22.03% |
2023 Q1 | 14.33 Million TWD | -30.9% |
2023 Q2 | 14.33 Million TWD | 0.0% |
2023 FY | 51.01 Million TWD | -31.63% |
2023 Q4 | 11.17 Million TWD | 0.0% |
2022 Q3 | 20.74 Million TWD | 0.0% |
2022 FY | 74.61 Million TWD | 25.78% |
2022 Q4 | 20.74 Million TWD | 0.0% |
2021 FY | 59.32 Million TWD | -14.41% |
2020 FY | 69.31 Million TWD | -6.01% |
2019 FY | 73.75 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | 79.299% |
GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | 82.184% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | 70.117% |
TTY Biopharm Company Limited | 3.22 Billion TWD | 98.417% |
Synmosa Biopharma Corporation | 2.11 Billion TWD | 97.594% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 97.624% |
Center Laboratories, Inc. | 618.09 Million TWD | 91.746% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | 82.171% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 89.115% |
InnoPharmax Inc. | 17.45 Million TWD | -192.238% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | 79.146% |
Excelsior Biopharma Inc. | 306.93 Million TWD | 83.379% |
DV Biomed Co., Ltd. | 764.27 Million TWD | 93.325% |
Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | 55.238% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 95.383% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 87.147% |
Alar Pharmaceuticals Inc. | 465.92 Million TWD | 89.051% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | 85.323% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -8517.568% |
Bioray Biotech Co., Ltd | 77.65 Million TWD | 34.301% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | 87.243% |